1. R&D Costs and Returns by Therapeutic Category

   • Joseph A. DiMasi
   • Henry G. Grabowski
   • John Vernon

   Clinical and Non-Clinical Drug Development 30 December 2004 Pages: 211 - 223

2. Electronic Patient Diaries in a Clinical Trial—The Holistic Approach

   • Heidi E. Shea
   • Charles Preston
   • Spencer Hudson

   Clinical and Non-Clinical Drug Development 30 December 2004 Pages: 225 - 238

3. From Informed Consent through Database Lock: An Interactive Clinical Trial Conducted Using the Internet

   • Kristin L. Eilenberg
   • Amy M. Hoover
   • Scott Segal

   Clinical and Non-Clinical Drug Development 30 December 2004 Pages: 239 - 251

4. Biotechnology Regulation: Views of the Authorities, Investors, and Product Developers in Finland

   • Outi Nieminen
   • Leena Rahkamo
   • Katrina Nordström

   Drug Regulation 30 December 2004 Pages: 253 - 264

5. Valuing the Drug Information Provided for Generics in Setting the Price of Generic Drugs in Japan

   • Hisashi Iijima
   • Teruyo Kurosaki
   • Makoto Shiragami

   Drug Regulation 30 December 2004 Pages: 265 - 272

6. The Regulation of Herbal Medicinal Products in Armenia

   • Emil Gabrielyan
   • Elmira Amroyan
   • Gagik Grigoryan

   Drug Regulation 30 December 2004 Pages: 273 - 281

7. A Statistical Design Consideration in Robotic Systems

   • Stan Altan
   • Areti Manola
   • Damaraju Raghavarao

   Statistics 30 December 2004 Pages: 283 - 286

8. Clinical Trial Design Issues for Chronic Hepatitis B

   • Yeong-Liang Lin

   Statistics 30 December 2004 Pages: 287 - 291

9. Practical Considerations in Developing an Automated Signaling Program within a Pharmacovigilance Department

   • Chuen L. Yee
   • Steve L. Klincewicz
   • Rick Wilson

   Drug Safety 30 December 2004 Pages: 293 - 300

10. Attitudes of Older Americans toward Direct-to-Consumer Advertising: Predictors of Impact

    • Jacqueline S. Marinac
    • Lincoln A. Godfrey
    • Sandra K. Willsie

    Drug Information 30 December 2004 Pages: 301 - 311